CSL Hong Kong Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU complex, Powder for injection (50 IU/mL FVIII)

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Von willebrand factor, Quantity: 1000 IU; Factor VIII, Quantity: 500 IU

Pieejams no:

CSL Behring Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Factor VIII,Von willebrand factor

Zāļu forma:

Injection, solution

Kompozīcija:

Excipient Ingredients: water for injections

Ievadīšanas:

Intravenous

Ārstēšanas norādes:

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

Produktu pārskats:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorizācija statuss:

Listed (Export Only)

Autorizācija datums:

2004-06-17